Baker McKenzie has advised Marvell Technology on its acquisition of Polariton Technologies, a Swiss-based developer of plasmonics-based silicon photonics devices, in a cross-border transaction spanning the US, Switzerland, and Belgium.
Tags :Alexander Fischer
DBAG Fund VIII, a fund managed by Deutsche Beteiligungs (DBAG), acquired the Hipp Technology Group, a development partner and medical technology contract manufacturer, from an investor group represented by Endura. In connection with the deal,
Baker McKenzie advised the majority shareholders of the Citieffe Group, including private equity firm Archimed, on the sale of their entire stake in Medistream – a Swiss company that owns Italian medical device manufacturer Citieffe SRL
Swiss-based Mageba Group completed a refinancing operation via a syndicated loan with a banking consortium led by UBS Switzerland. In connection with the deal, Niederer Kraft Frey (NKF) advised UBS Switzerland, as well as the
Landis+Gyr divested its EMEA business to private equity investor Aurelius, for an enterprise value of USD 215 m. The divestment encompasses five production sites across EMEA and involves a workforce of approximately 2,700 employees. In connection
Baker McKenzie advised Swiss medical regeneration technologies specialist Geistlich Pharma (Geistlich) on its acquisition of a minority stake in TRI Dental Implants (TRI), a provider of digital implant solutions which developed an abutment-free dental implant
Abacus Medicine Group – a Danish group active across the modern healthcare sector – completed the acquisition of Swiss Cardio Technologies. In connection the deal Shellenberg Wittmer advised the buyer, while Baker McKenzie Switzerland represented the shareholders
Swiss mid-markets specialist White Peaks completed the acquisition of pom+ Group from its current management team. In connection with the deal, Bär & Karrer advised White Peaks, while Baker McKenzie Switzerland, with support from
Baker McKenzie advised intranet platforms specialist LumApps, on legal due diligence matters in connection with its merger agreement with Beekeeper. With a combined valuation exceeding USD 1 billion, the operation will result in the creation an
Baker McKenzie advised Swedish life-saving solutions specialist Safe Life, on the acquisition of the Swiss company resQshock. The context Headquartered in Buttikon, resQshock specialises in the production automated external defibrillators (AEDs). Pursuant to the deal,
